WallStSmart

Amrize Ltd (AMRZ)vsCapstone Holding Corp. Common Stock (CAPS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Amrize Ltd generates 26321% more annual revenue ($11.81B vs $44.72M). AMRZ leads profitability with a 10.0% profit margin vs -12.4%. AMRZ earns a higher WallStSmart Score of 55/100 (C-).

AMRZ

Buy

55

out of 100

Grade: C-

Growth: 3.3Profit: 6.5Value: 7.3Quality: 5.8
Piotroski: 3/9

CAPS

Hold

37

out of 100

Grade: F

Growth: 4.0Profit: 2.0Value: 5.0Quality: 5.0
Piotroski: 5/9Altman Z: -4.90
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AMRZSignificantly Overvalued (-119.3%)

Margin of Safety

-119.3%

Fair Value

$26.88

Current Price

$56.12

$29.24 premium

UndervaluedFair: $26.88Overvalued

Intrinsic value data unavailable for CAPS.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMRZ2 strengths · Avg: 8.0/10
Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$1.65B8/10

Generating 1.6B in free cash flow

CAPS1 strengths · Avg: 10.0/10
Price/BookValuation
0.2x10/10

Reasonable price relative to book value

Areas to Watch

AMRZ4 concerns · Avg: 3.3/10
P/E RatioValuation
25.9x4/10

Moderate valuation

EPS GrowthGrowth
3.6%4/10

3.6% earnings growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Revenue GrowthGrowth
-0.4%2/10

Revenue declined 0.4%

CAPS4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$6.37M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-20.2%2/10

ROE of -20.2% — below average capital efficiency

Free Cash FlowQuality
$-16,0002/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : AMRZ

The strongest argument for AMRZ centers on Price/Book, Free Cash Flow. PEG of 1.40 suggests the stock is reasonably priced for its growth.

Bull Case : CAPS

The strongest argument for CAPS centers on Price/Book. Revenue growth of 10.8% demonstrates continued momentum.

Bear Case : AMRZ

The primary concerns for AMRZ are P/E Ratio, EPS Growth, Piotroski F-Score.

Bear Case : CAPS

The primary concerns for CAPS are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

AMRZ profiles as a value stock while CAPS is a turnaround play — different risk/reward profiles.

CAPS is growing revenue faster at 10.8% — sustainability is the question.

AMRZ generates stronger free cash flow (1.6B), providing more financial flexibility.

Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AMRZ scores higher overall (55/100 vs 37/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amrize Ltd

BASIC MATERIALS · BUILDING MATERIALS · USA

Amrize Ltd (AMRZ) is an innovative technology company at the forefront of the digital health and wellness sector, striving to transform healthcare delivery through advanced technologies and data-driven solutions. With a strong emphasis on enhancing patient outcomes and increasing healthcare accessibility, Amrize engages in extensive research and development to address the growing demand for scalable health solutions. The company’s strategic initiatives position it to play a pivotal role in the evolving landscape of healthcare, making it a critical player in the advancement of modern healthcare systems.

Visit Website →

Capstone Holding Corp. Common Stock

BASIC MATERIALS · BUILDING MATERIALS · USA

Capstone Holding Corp. The company is headquartered in Alsip, Illinois.

Visit Website →

Want to dig deeper into these stocks?